359 related articles for article (PubMed ID: 24447345)
1. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development.
Waldner MJ; Neurath MF
Semin Immunol; 2014 Feb; 26(1):75-9. PubMed ID: 24447345
[TBL] [Abstract][Full Text] [Related]
2. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
[TBL] [Abstract][Full Text] [Related]
3. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
Azer SA
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
[TBL] [Abstract][Full Text] [Related]
4. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer.
Atreya R; Neurath MF
Curr Drug Targets; 2008 May; 9(5):369-74. PubMed ID: 18473764
[TBL] [Abstract][Full Text] [Related]
5. Dietary cocoa inhibits colitis associated cancer: a crucial involvement of the IL-6/STAT3 pathway.
Saadatdoust Z; Pandurangan AK; Ananda Sadagopan SK; Mohd Esa N; Ismail A; Mustafa MR
J Nutr Biochem; 2015 Dec; 26(12):1547-58. PubMed ID: 26355019
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in colitis associated cancer: potential drug targets?
Waldner MJ; Neurath MF
Inflamm Allergy Drug Targets; 2008 Sep; 7(3):187-94. PubMed ID: 18782026
[TBL] [Abstract][Full Text] [Related]
7. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
8. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
9. The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer.
Luo C; Zhang H
Mediators Inflamm; 2017; 2017():5126048. PubMed ID: 28852270
[TBL] [Abstract][Full Text] [Related]
10. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
11. Inflammation in sporadic colorectal cancer.
Moossavi S; Bishehsari F
Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer mouse models: integrating inflammation and the stroma.
Ernst M; Ramsay RG
J Gastroenterol Hepatol; 2012 Jan; 27(1):39-50. PubMed ID: 22188027
[TBL] [Abstract][Full Text] [Related]
13. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review).
Wang SW; Sun YM
Int J Oncol; 2014 Apr; 44(4):1032-40. PubMed ID: 24430672
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
Gui X; Iacucci M; Ghosh S
Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.
Mitsuyama K; Matsumoto S; Masuda J; Yamasakii H; Kuwaki K; Takedatsu H; Sata M
Anticancer Res; 2007; 27(6A):3749-56. PubMed ID: 17970038
[TBL] [Abstract][Full Text] [Related]
16. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.
Abraham C; Cho JH
Annu Rev Med; 2009; 60():97-110. PubMed ID: 18976050
[TBL] [Abstract][Full Text] [Related]
17. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer.
Atreya R; Neurath MF
Clin Rev Allergy Immunol; 2005 Jun; 28(3):187-96. PubMed ID: 16129903
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD4+ T cell cytokine genes in the colorectal mucosa of inflammatory colorectal polyps in miniature dachshunds.
Ohta H; Takada K; Torisu S; Yuki M; Tamura Y; Yokoyama N; Osuga T; Lim SY; Murakami M; Sasaki N; Nakamura K; Yamasaki M; Takiguchi M
Vet Immunol Immunopathol; 2013 Oct; 155(4):259-63. PubMed ID: 23953369
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
Fonseca-Camarillo G; Yamamoto-Furusho JK
Inflamm Bowel Dis; 2015 Sep; 21(9):2188-93. PubMed ID: 26111210
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer.
Velikova TV; Miteva L; Stanilov N; Spassova Z; Stanilova SA
World J Gastroenterol; 2020 Apr; 26(16):1912-1925. PubMed ID: 32390702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
